Page 68 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 68
THURSDAY, APRIL 23, 2015

Parallel Session: Non-invasive marker of liver disease: Management Strauss 1

Chairs:
Mireen Friedrich-Rust, Germany
Massimo Pinzani, The United Kingdom

SCIENTIFIC PROGRAMME ABSTRACT EFFECTIVENESS OF TREATMENT INITIATION BASED
O017 ON FIBROSIS STAGE ASSESSED BY METHODS OF
16:00 - 16:15 FIBROSIS DIAGNOSIS IN TERMS OF 5-YEAR INCIDENCE
OF MORBI-MORTALITY
ABSTRACT Sylvie Deuffic-Burban, France
O017A
16:15 - 16:30 NON-INVASIVE TOOLS AND RISK OF VARICES AND
CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN
ABSTRACT COMPENSATED CIRRHOSIS: THE “ANTICIPATE” STUDY
O018 Juan G. Abraldes, Canada
16:30 - 16:45
2D-SHEAR WAVE ELASTOGRAPHY IS EQUIVALENT
ABSTRACT OR SUPERIOR TO TRANSIENT ELASTOGRAPHY FOR
O019 LIVER FIBROSIS ASSESSMENT: RESULTS FROM AN
16:45 - 17:00 INDIVIDUAL PATIENT DATA BASED META-ANALYSIS
Eva Herrmann, Germany
ABSTRACT
O020 THE VALUE OF DIFFERENT NON-INVASIVE TESTS
17:00 - 17:15 FOR PREDICTING THE PRESENCE OF CLINICALLY
SIGNIFICANT PORTAL HYPERTENSION AND
ABSTRACT ESOPHAGEAL VARICES IN CIRRHOTIC PATIENTS
O021 Simona Bota, Austria
17:15 - 17:30
MAGNETIC RESONANCE ELASTOGRAPHY IS
SUPERIOR TO CLINICAL PREDICTION MODELS FOR
DETERMINATION OF ADVANCED FIBROSIS IN PATIENTS
WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A
PROSPECTIVE STUDY
Jeffrey Y. Cui, The United States

NON-INVASIVE SCREENING OF LARGE ESOPHAGEAL
VARICES USING ENDOSCOPIC CAPSULE AND/OR LIVER
FIBROSIS TESTS
Paul Cales, France

68 The International Liver Congress™ 2015 • ILC Programme
   63   64   65   66   67   68   69   70   71   72   73